What treatment people got after glioblastoma came back
Original title: Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
These treatments are already used in people, but this study only watched what happened and does not prove which one works best.
The short version
This study looked at what doctors actually gave people after a grade 4 brain tumor came back or grew.
What was studied. Researchers looked at records from 275 people with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a grade 4 brain tumor. All of them got more treatment after their tumor came back or grew.
What they found. Drug treatment was the most common choice. 85% got drug treatment, and 67% got a drug called bevacizumab on its own. 29% had surgery again, and only 9 people had radiation a second time. After the tumor came back, survival was about 9.5 months.
What this means, and what it doesn't
What it could mean: This is a picture of the care people really get when glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary returns. Drugs, most often bevacizumab, are the usual next step. Surgery again is less common, and repeat radiation is rare. In this study, having surgery again did not lead to longer life than drug treatment alone once other things were taken into account. You can ask your own doctor which of these options fits your situation.
What it doesn't mean: This is not a new treatment. It is not a cure and does not promise one. Researchers only looked back at past records. They did not test one treatment against another in a fair trial. The people who had surgery again were younger and in better health, so the groups were not the same. This cannot tell you which treatment is best for you.
Source: PubMed, July 23, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.